Title:
HETEROCYCLIC COMPOUNDS
Document Type and Number:
WIPO Patent Application WO/2023/125681
Kind Code:
A1
Abstract:
Disclosed herein is a compound of Formula (I) having the following structure for activating T cells, promoting T cell proliferation, and/or exhibiting antitumor activity, a method of using the compounds disclosed herein for treating cancer, and a pharmaceutical composition comprising the same.
Inventors:
ZHANG GUOLIANG (CN)
NI ZHIKUN (CN)
MIAO JIANZHUANG (CN)
WANG CE (CN)
NI ZHIKUN (CN)
MIAO JIANZHUANG (CN)
WANG CE (CN)
Application Number:
PCT/CN2022/142891
Publication Date:
July 06, 2023
Filing Date:
December 28, 2022
Export Citation:
Assignee:
BEIGENE LTD (GB)
ZHANG GUOLIANG (CN)
ZHANG GUOLIANG (CN)
International Classes:
C07D403/14; A61K31/4188; A61K31/496; A61P35/00; C07D487/04
Domestic Patent References:
WO2021023105A1 | 2021-02-11 | |||
WO2021243421A1 | 2021-12-09 | |||
WO2020210970A1 | 2020-10-22 | |||
WO2021088901A1 | 2021-05-14 | |||
WO2014173241A1 | 2014-10-30 | |||
WO2021013083A1 | 2021-01-28 | |||
WO2015086501A1 | 2015-06-18 | |||
WO2021133752A1 | 2021-07-01 |
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF:
Previous Patent: ELECTRICALLY HEATED AEROSOL GENERATING SYSTEM
Next Patent: MEDICAL DEVICE AND C-ARM BASED DEVICE THEREOF
Next Patent: MEDICAL DEVICE AND C-ARM BASED DEVICE THEREOF